Black gay men face major PrEP access gaps due to cost, stigma, mistrust, and provider silence—despite high HIV impact; ...
The quest for a single-pill once-a-day treatment for HIV became a reality when the FDA approved Atripla on July 12. It combines the already approved drugs efavirenz (Sustiva), tenofovir (Viread), and ...
Observers are calling proposed changes to state-funded HIV assistance its biggest rollback since the aid went into place.
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...
MSD’s once-daily pill for human immunodeficiency virus (HIV) has proved non-inferior to Gilead’s Biktarvy (bictegravir/emtricitabine/tenofovir alafenamidei) in a ...
Advocacy groups from 30 countries are urging Merck to create a global access strategy for its once-a-month HIV prevention ...
By Chris Takudzwa Muronzi HARARE, Feb 19 (Reuters) - Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the country one of the first ...
Florida's state-funded HIV drug assistance program is facing a significant rollback, impacting drug availability and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results